CPhI Exhibitors Announce Their Latest Products Set to Drive Tomorrow's Pharmaceutical Industry

AMSTERDAM, October 1, 2014 /PRNewswire/ --

CPhI Worldwide, part of UBM Live's Pharmaceutical Portfolio, today released some of the new product announcements from exhibiting companies ahead of the event in Paris next week (October 7-9^th 2014), allowing attendees to see some of the latest innovations and news.

     (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

VxP Pharma Expands Commercial Service Offering 

VxP Pharma Services declared an expansion of their service offering to include process development and commercial manufacturing for multiple dosage forms. Commercially available dosage forms offered by VxP now include; Oral Solids and Oral Liquids, Sterile Liquids and Sterile Powders, Ophthalmic Products and many more.

VxP Pharma CEO - Raymond E. Peck says, "Although the majority of our business at VxP involves small and large molecule development programs for clinical trials, we have had an increasing number of requests for commercial scale development and production. In order to respond to this increase in demand, we have expanded our commercial services capacity for both the pharmaceutical and biotech industries."

Thermodynamic Power 

The PRESTO^® A80, W80, A80t and W80t presented by JULABO are additional members of the entirely new PRESTO^® family. They unite high efficiency with unequaled power for modern laboratory and industrial plants for all applications be it reactor temperature control or material stress tests or temperature simulation. The instruments cover a working temperature range from -80  C to +250  C, provide 1.2 kW cooling capacity, and they are robust and reliable even at high room temperatures up to +40  C. The heating capacity of the A80 and W80 is 1.8 kW.

JULABO offers its customers installation and calibration services, documentation for instrument qualification, and user training so users can start using their instruments right away and benefit from years of safe operation.

Intech, Synmosa Group acquired foreign-owned plant - Accelerate the expansion in global market 

Intech Biopharm, Synmosa Group that owns the technology of inhalation drug delivery company, announced that it has spent $30M USD to acquire a new plant, to be put into production in 2016. Intech intends to use the 21,500 square-meters facility in Taiwan to further enhance and scale its proprietary manufacturing capacity for respiratory products. The acquisition comes in response to growing demands for pMDI/DPI and Nasal Spray products.

Peter Lin, Chairman of Synmosa Group, claims "its products are marketed in Taiwan and China, and soon will authorize international pharmaceutical companies expanding and bringing those quality products to the global market. This plant acquiring evidently benefits its expansion".

New Braille printing developed for plastic pharmaceutical packaging 

Nolato Medical Pharma Packaging now have the ability to print Braille directly onto plastic containers.  The process developed by Nolato Jaycare in the UK allows a lay down of UV cured ink with a thickness of up to 0.5mm, directly onto the surface of a plastic container. The screen printing facilities onsite were adapted to maintain an even and consistent print height, which is crucial for any braille.  

Although originally developed for printing Braille on to containers, this process also can be used in traditional screen printing allowing customers the opportunity of highlighting particular areas of their packaging artwork, on their logos and branding, by offsetting the print from the surface of the container.

About CPhI 

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also includes; CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte- France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre- Tokyo). CPhI Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75, Moscow Russia); CPhI, P-MEC and Innopack South East Asia (26-28 May, 2015 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (23-25 June, 2014 at SNIEC- Shanghai, China); CPhI, ICSE Korea (7-9 September, 2015 at the COEX- Seoul, South Korea).

About UBM Live 

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis    
De Facto Communications
T: +44-207-203-6745 / 6740
E: [email protected] / [email protected]

SOURCE UBM Live